Return On Equity in % of Astria Therapeutics, Inc. from Q1 2016 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Astria Therapeutics, Inc. quarterly and annual Return On Equity history and change rate from Q1 2016 to Q3 2025.
  • Astria Therapeutics, Inc. Return On Equity for the quarter ending 30 Sep 2025 was -45%, a 46% decline year-over-year.
  • Astria Therapeutics, Inc. annual Return On Equity for 2024 was -27%, a 21% increase from 2023.
  • Astria Therapeutics, Inc. annual Return On Equity for 2023 was -35%, a 9% increase from 2022.
  • Astria Therapeutics, Inc. annual Return On Equity for 2022 was -38%, a 86% increase from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Astria Therapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -45% -14% -46% 01 Jul 2025 30 Sep 2025
Q2 2025 -39% -6% -18% 01 Apr 2025 30 Jun 2025
Q1 2025 -33% -1% -1.6% 01 Jan 2025 31 Mar 2025
Q4 2024 -27% +7% +21% 01 Oct 2024 31 Dec 2024
Q3 2024 -31% -4% -15% 01 Jul 2024 30 Sep 2024
Q2 2024 -33% -6% -24% 01 Apr 2024 30 Jun 2024
Q1 2024 -33% -3% -11% 01 Jan 2024 31 Mar 2024
Q4 2023 -35% +3% +9% 01 Oct 2023 31 Dec 2023
Q3 2023 -27% +16% +38% 01 Jul 2023 30 Sep 2023
Q2 2023 -26% +12% +31% 01 Apr 2023 30 Jun 2023
Q1 2023 -30% +3% +8% 01 Jan 2023 31 Mar 2023
Q4 2022 -38% +232% +86% 01 Oct 2022 31 Dec 2022
Q3 2022 -43% +333% +88% 01 Jul 2022 30 Sep 2022
Q2 2022 -38% +590% +94% 01 Apr 2022 30 Jun 2022
Q1 2022 -32% +1978% +98% 01 Jan 2022 31 Mar 2022
Q4 2021 -270% -194% -252% 01 Oct 2021 31 Dec 2021
Q3 2021 -376% -302% -410% 01 Jul 2021 30 Sep 2021
Q2 2021 -628% -559% -817% 01 Apr 2021 30 Jun 2021
Q1 2021 -2010% -1944% -2947% 01 Jan 2021 31 Mar 2021
Q4 2020 -77% -14% -22% 01 Oct 2020 31 Dec 2020
Q3 2020 -74% -12% -19% 01 Jul 2020 30 Sep 2020
Q2 2020 -69% -9% -16% 01 Apr 2020 30 Jun 2020
Q1 2020 -66% -9% -16% 01 Jan 2020 31 Mar 2020
Q4 2019 -63% +14% +18% 01 Oct 2019 31 Dec 2019
Q3 2019 -62% +29% +32% 01 Jul 2019 30 Sep 2019
Q2 2019 -59% +65% +52% 01 Apr 2019 30 Jun 2019
Q1 2019 -57% +119% +68% 01 Jan 2019 31 Mar 2019
Q4 2018 -77% +73% +49% 01 Oct 2018 31 Dec 2018
Q3 2018 -91% +45% +33% 01 Jul 2018 30 Sep 2018
Q2 2018 -124% -9% -7.5% 01 Apr 2018 30 Jun 2018
Q1 2018 -175% -63% -56% 01 Jan 2018 31 Mar 2018
Q4 2017 -150% -47% -46% 01 Oct 2017 31 Dec 2017
Q3 2017 -136% -45% -49% 01 Jul 2017 30 Sep 2017
Q2 2017 -115% -35% -44% 01 Apr 2017 30 Jun 2017
Q1 2017 -113% -48% -74% 01 Jan 2017 31 Mar 2017
Q4 2016 -103% 01 Oct 2016 31 Dec 2016
Q3 2016 -91% 01 Jul 2016 30 Sep 2016
Q2 2016 -80% 01 Apr 2016 30 Jun 2016
Q1 2016 -65% 01 Jan 2016 31 Mar 2016

Astria Therapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -27% +7% +21% 01 Jan 2024 31 Dec 2024
2023 -35% +3% +9% 01 Jan 2023 31 Dec 2023
2022 -38% +232% +86% 01 Jan 2022 31 Dec 2022
2021 -270% -194% -252% 01 Jan 2021 31 Dec 2021
2020 -77% -14% -22% 01 Jan 2020 31 Dec 2020
2019 -63% +14% +18% 01 Jan 2019 31 Dec 2019
2018 -77% +73% +49% 01 Jan 2018 31 Dec 2018
2017 -150% -47% -46% 01 Jan 2017 31 Dec 2017
2016 -103% 01 Jan 2016 31 Dec 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.